From: An investigation of oxidant/antioxidant balance in patients with migraine: a case-control study
Variable | Controls (n = 19) | Episodic Migraineurs (n = 44) | Chronic Migraineurs (n = 27) | P value | |||
---|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | SD | ||
CAT (pg/ml) | 8075.95a | 462.79 | 5452.14 a | 891.98 | 3354.00 a | 414.57 | 0.000 |
SOD (pmol/ml) | 5117.37 a | 183.90 | 5086.23 b | 514.48 | 4210.63 a,b | 308.28 | 0.000 |
GPx-1 (pg/ml) | 4168.58 a | 322.74 | 4284.23 b | 178.71 | 4441.04 a,b | 234.15 | 0.001 |
TEAC (pmol/ml) | 136,203.68 a | 7023.84 | 137,281.59 b | 14,685.31 | 103,637.41 a,b | 7197.49 | 0.000 |
NO (pg/ml) | 5101.68 a | 489.09 | 6461.23 a | 744.32 | 7329.81 a | 775.34 | 0.000 |
MDA (pg/ml) | 3125.53 a | 251.73 | 3844.93 a | 349.75 | 5005.19 a | 138.38 | 0.000 |